PEPFAR支持的HIV和结核分子诊断网络对16国COVID-19检测准备工作的贡献
本文描述了16个中低收入国家如何利用PEPFAR支持的HIV和结核分子诊断网络资源开展SARS-CoV-2检测。
要点
- PEPFAR支持的HIV和结核诊断网络在16国参与SARS-CoV-2检测。
- 109个集中化HIV病毒载量和早期婴儿诊断实验室报告开展检测。
核心结论
- PEPFAR支持的诊断网络为16个中低收入国家的COVID-19紧急诊断检测提供了广泛资源。
研究设计与样本
- 向27个PEPFAR支持的国家或地区发送含46项指标的电子表格模板,评估2020年4月1日至2021年3月31日期间PEPFAR支持诊断网络用于COVID-19疫情应对活动的情况。
- 16个国家报告109个PEPFAR支持的集中化HIV病毒载量和早期婴儿诊断实验室及138个分散的HIV和结核站点开展SARS-CoV-2检测。
主要发现
- 109个PEPFAR支持的集中化HIV病毒载量和早期婴儿诊断实验室报告在16个国家开展SARS-CoV-2检测。
- 138个分散的HIV和结核站点报告在16个国家开展SARS-CoV-2检测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The US President's Emergency Plan for AIDS Relief (PEPFAR) supports molecular HIV and tuberculosis diagnostic networks and information management systems in low- and middle-income countries. We describe how national programs leveraged these PEPFAR-supported laboratory resources for SARS-CoV-2 testing during the COVID-19 pandemic. We sent a spreadsheet template consisting of 46 indicators for assessing the use of PEPFAR-supported diagnostic networks for COVID-19 pandemic response activities during April 1, 2020, to March 31, 2021, to 27 PEPFAR-supported countries or regions. A total of 109 PEPFAR-supported centralized HIV viral load and early infant diagnosis laboratories and 138 decentralized HIV and TB sites reported performing SARS-CoV-2 testing in 16 countries. Together, these sites contributed to >3.4 million SARS-CoV-2 tests during the 1-year period. Our findings illustrate that PEPFAR-supported diagnostic networks provided a wide range of resources to respond to emergency COVID-19 diagnostic testing in 16 low- and middle-income countries.
引用
- Romano ER, Sleeman K, Hall-Eidson P, et al. Contribution of PEPFAR-Supported HIV and TB Molecular Diagnostic Networks to COVID-19 Testing Preparedness in 16 Countries. Emerg Infect Dis. 2022. PMID: 36502414. doi:10.3201/eid2813.220789
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。